Lars Henning Engelholm
Department of Clinical Medicine
Blegdamsvej 3
2200 2200 København N
Department of Biology
Ole Maaløes Vej 5
2200 2200 København N
ORCID: 0000-0002-6616-1232
1 - 1 out of 1Page size: 10
- 1998
- Published
Plasminogen activator inhibitor type 1 (PAI-1) in cancer: A potential new target for antiinvasive and antimetastatic therapy
Frandsen, T. L., Stephens, R. W., Pedersen, A. N., Engelholm, Lars Henning, Holst-Hansen, C. & Brünner, N., Aug 1998, In: Drugs of the Future. 23, 8, p. 873-883 11 p.Research output: Contribution to journal › Review › Research › peer-review
ID: 9647887
Most downloads
-
2935
downloads
Loss of miR-10a activates Lpo and collaborates with activated Wnt signaling in inducing intestinal Neoplasia in female mice
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
263
downloads
The collagen receptor uPARAP/Endo180 as a novel target for antibody-drug conjugate mediated treatment of mesenchymal and leukemic cancers
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
261
downloads
CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1–Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma
Research output: Contribution to journal › Journal article › Research › peer-review
Published